GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Fangsheng Pharmaceutical Co Ltd (SHSE:603998) » Definitions » EV-to-FCF

Hunan Fangsheng Pharmaceutical Co (SHSE:603998) EV-to-FCF : 47.14 (As of Apr. 17, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Hunan Fangsheng Pharmaceutical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Hunan Fangsheng Pharmaceutical Co's Enterprise Value is ¥4,907 Mil. Hunan Fangsheng Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥104 Mil. Therefore, Hunan Fangsheng Pharmaceutical Co's EV-to-FCF for today is 47.14.

The historical rank and industry rank for Hunan Fangsheng Pharmaceutical Co's EV-to-FCF or its related term are showing as below:

SHSE:603998' s EV-to-FCF Range Over the Past 10 Years
Min: -1591.16   Med: 27.85   Max: 3631.23
Current: 46.05

During the past 13 years, the highest EV-to-FCF of Hunan Fangsheng Pharmaceutical Co was 3631.23. The lowest was -1591.16. And the median was 27.85.

SHSE:603998's EV-to-FCF is ranked worse than
73.99% of 546 companies
in the Drug Manufacturers industry
Industry Median: 23.125 vs SHSE:603998: 46.05

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-17), Hunan Fangsheng Pharmaceutical Co's stock price is ¥9.82. Hunan Fangsheng Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.610. Therefore, Hunan Fangsheng Pharmaceutical Co's PE Ratio (TTM) for today is 16.10.


Hunan Fangsheng Pharmaceutical Co EV-to-FCF Historical Data

The historical data trend for Hunan Fangsheng Pharmaceutical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Fangsheng Pharmaceutical Co EV-to-FCF Chart

Hunan Fangsheng Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -103.91 41.55 3,587.41 28.60 -41.15

Hunan Fangsheng Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -82.36 -41.15 -814.61 131.50 56.60

Competitive Comparison of Hunan Fangsheng Pharmaceutical Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Fangsheng Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Fangsheng Pharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Fangsheng Pharmaceutical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Hunan Fangsheng Pharmaceutical Co's EV-to-FCF falls into.


;
;

Hunan Fangsheng Pharmaceutical Co EV-to-FCF Calculation

Hunan Fangsheng Pharmaceutical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4906.565/104.077
=47.14

Hunan Fangsheng Pharmaceutical Co's current Enterprise Value is ¥4,907 Mil.
Hunan Fangsheng Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥104 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Fangsheng Pharmaceutical Co  (SHSE:603998) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Hunan Fangsheng Pharmaceutical Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=9.82/0.610
=16.10

Hunan Fangsheng Pharmaceutical Co's share price for today is ¥9.82.
Hunan Fangsheng Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.610.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Hunan Fangsheng Pharmaceutical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Hunan Fangsheng Pharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Fangsheng Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 789, Lusong Road, Changsha High-tech Zone, Changsha, CHN
Hunan Fangsheng Pharmaceutical Co Ltd is engaged in pharmaceutical business. The company's business scope covers the production and sales of tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, spray lotion, small volume injections, and bulk pharmaceutical chemicals. Its product offerings include Cefixime Tablets, Cefpiramide for Injection, Cefprozil Tablets, Fleroxacin Dispersible Tablets, and others.
Executives
He Shi senior management
Xiao Han Qing senior management
Liu Xin He senior management
Chen Bo Director
Chen Ai Chun Director
Li Zhi Heng senior management
Zhou Wei En senior management
Zhang Qing Hua Director
Huang Min Director
Zhou Xiao Li senior management
Fang Jin Cheng Director
Fang Chuan Long Supervisors
Tan Yuan Ming Director

Hunan Fangsheng Pharmaceutical Co Headlines

No Headlines